###begin article-title 0
###xml 29 34 <span type="species:ncbi:9606">human</span>
Endogenous growth hormone in human retinal ganglion cells correlates with cell survival
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 115 120 <span type="species:ncbi:9031">chick</span>
###xml 414 417 <span type="species:ncbi:10116">rat</span>
###xml 489 494 <span type="species:ncbi:9606">human</span>
###xml 637 642 <span type="species:ncbi:9606">human</span>
Locally synthesized growth hormone (GH) may act as a survival factor in several tissues. Experimental studies with chick retinal ganglion cells (RGCs) suggest that GH, synthesized within the developing retina, may have autocrine or paracrine roles in the regulation of the waves of cell death characteristic of RGC differentiation. There is also evidence that GH may have a similar neuroprotective function in the rat retina, however, there is no information concerning such a role in the human retina. In this paper we extended our earlier work by determining whether the local expression of retinal GH correlates with RGC apoptosis in human retinas.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 77 82 <span type="species:ncbi:9606">human</span>
###xml 236 241 <span type="species:ncbi:9606">human</span>
In the absence of experimental approaches to survival factor function in the human retina, we have used a correlative immunocytochemical technique to determine how the expression of GH relates to cell death in RGCs. We used sections of human retinas, taken postmortem, that we double-labeled for GH and apoptotic cell death using  dUTP nick end labeling (TUNEL).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
We found that approximately 35% of cells in the ganglion cell layer (GCL) were both GH positive and GH receptor (GHR) positive, and that GH colocalized with GHR in these cells. However, none of the apoptotic cells in the GCL were GH immunoreactive. Labeling of sections with the RGC marker, synuclein, indicated that at least 95% of the cells in the GCL were RGCs, leading us to conclude that the majority of the cells that we have examined in the GCL are RGCs.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 97 102 <span type="species:ncbi:9031">chick</span>
###xml 154 159 <span type="species:ncbi:9606">human</span>
The results are consistent with the earlier proposal, based on in vivo and in vitro experimental chick embryo studies, that GH promotes survival in adult human RGCs.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 153 154 153 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 312 313 312 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r4">4</xref>
###xml 586 587 586 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 659 660 659 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 780 781 780 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 782 783 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 926 928 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 106 111 <span type="species:ncbi:9031">chick</span>
###xml 147 151 <span type="species:ncbi:10116">rats</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
###xml 323 328 <span type="species:ncbi:9031">chick</span>
We have previously shown that growth hormone (GH) is present in the retina and vitreous of the developing chick embryo [1], in perinatal and adult rats [2], and in the adult human [3]. In these tissues, GH is synthesized in the retinal ganglion cells (RGCs) from where it is secreted and stored in the vitreous [4]. During chick embryo development, this GH appears in the retina and vitreous before the functional differentiation of the pituitary gland, and it appears to act locally in the retina as an autocrine or paracrine growth and differentiation factor promoting cell survival [5,6]. Like other paracrine growth factors, which act during development [7], GH appears to activate specific intracellular antiapoptotic signaling pathways in the RGCs leading to cell survival [8,9]. It is thus thought that retinal GH is an endogenous neuroprotective agent that may regulate programmed cell death in the developing retina [10].
###end p 11
###begin p 12
###xml 58 59 58 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 163 168 <span type="species:ncbi:9606">human</span>
Since GH is present in adult human and mammalian retinas [2,3], we have sought to determine whether there is any evidence that GH might also be neuroprotective in human RGCs in which it is present. This is of potential significance since glaucoma is a disease of RGC degeneration in the elderly [11], which may be ameliorated by exogenous neurotrophic factors such as brain-derived neurotrophic factor (BDNF [12]). A positive correlation between the presence of GH and RGC survival might therefore provide a rationale for considering GH as a possible therapeutic RGC neuroprotective agent.
###end p 12
###begin p 13
###xml 51 56 <span type="species:ncbi:9606">human</span>
In the present study, we have examined sections of human retinas for the presence of GH in the cells of the RGC layer, and correlated this with the occurrence of RGC death using the method of  dUTP nick end-labeling (TUNEL). We found that none of the cells in the ganglion cell layer (GCL) that expressed GH were TUNEL-positive, suggesting that the presence of GH in the RGCs is likely involved in the promotion of cell survival.
###end p 13
###begin title 14
Methods
###end title 14
###begin p 15
###xml 34 39 <span type="species:ncbi:9606">human</span>
Paraffin wax-embedded sections of human retinas, taken postmortem, were obtained from Dr. Yeni Yucel, Department of Ophthalmology and Vision Sciences, University of Toronto (Toronto, Ontario). Experiments were performed after approval by the Health Research Ethics Board of the University of Alberta. The formalin-fixed specimens used in this study were taken from three different cadavers: a 74-year-old male (cause of death: myocardial infarction; specimen fixed 11 h postmortem); an 81-year-old male (cause of death: myocardial infarction; specimen fixed 2 h postmortem); and a 69-year-old male (cause of death: amyotrophic lateral sclerosis; specimen fixed 13 h postmortem). Results were consistent between sections from each of these individuals.
###end p 15
###begin p 16
###xml 562 563 556 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 566 567 560 561 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 581 582 575 576 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 584 585 578 579 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1337 1338 1330 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 1339 1341 1332 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 1342 1344 1335 1337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 172 178 <span type="species:ncbi:9986">rabbit</span>
###xml 184 189 <span type="species:ncbi:9606">human</span>
###xml 329 333 <span type="species:ncbi:9925">goat</span>
###xml 339 345 <span type="species:ncbi:9986">rabbit</span>
###xml 675 680 <span type="species:ncbi:10090">mouse</span>
###xml 686 691 <span type="species:ncbi:9606">human</span>
###xml 813 817 <span type="species:ncbi:9925">goat</span>
###xml 823 828 <span type="species:ncbi:10090">mouse</span>
###xml 1214 1220 <span type="species:ncbi:9986">rabbit</span>
###xml 1231 1236 <span type="species:ncbi:10090">mouse</span>
###xml 1322 1327 <span type="species:ncbi:9606">human</span>
For immunocytochemical double labeling, the sections were dewaxed and blocked for 1 h in 3% BSA (BSA) and then incubated overnight, at 4 degreesC, with a 1:200 dilution of rabbit anti-human GH (provided by Dr. A. F. Parlow, National Hormone and Peptide Program, Torrance, CA), followed by a 2 h incubation in a 1:200 dilution of goat-anti-rabbit secondary antibody that was conjugated to Alexa-Fluor 488 (green; Invitrogen, Carlsbad, CA). All washings mentioned in this paragraph were done in phosphate buffered saline (PBS). The PBS contained: NaCl, 7.2 g/l; Na2HPO4, 1.48 g/l; KH2PO4, 0.43 g/l. After washing, sections were then incubated overnight in 30 mug/ml Mab 263, a mouse anti-human GH receptor (GHR) monoclonal antibody (AbCam, Cambridge, MA). Sections were then washed and incubated for 2 h with 1:200 goat-anti-mouse Alexa Fluor 594 (red; Invitrogen). After washing, sections were then incubated with 4', 6'-diamino-2-phenylindole (DAPI) for 2 min to stain nuclei. The labeled sections were then examined by a confocal microscope (Model LSM 510; Carl Zeiss Canada Ltd., Toronto, Ontario), equipped with appropriate lasers. In negative controls, the two primary antibodies were replaced with non-immune rabbit serum and mouse IgG. The primary antibodies have been used previously for GH and GHR localization in human tissues [3,13,14].
###end p 16
###begin p 17
###xml 155 157 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 158 160 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
To confirm the identity of cells in the GCL, we used C-20 (Santa Cruz Biotechnology Inc., Santa Cruz, CA), a polyclonal antibody, against gamma-synuclein [15,16]. This antibody was used at a dilution of 1:50 for 2 h at room temperature, and its specificity was confirmed by pre-absorption with the blocking peptide (C-20P) supplied by the company. Double labeling for GH and synuclein was performed by initially incubating sections overnight in GH antiserum followed by incubation with anti-synuclein.
###end p 17
###begin p 18
For the TUNEL technique, sections were dewaxed and washed in PBS before they were treated with 2.5 mug/ml proteinase K for 10 min at room temperature. Sections were then treated for 5 min with a TdT buffer that consisted of 30 mM Trizma base, 140 mM sodium cacodylate, and 1 mM cobalt chloride (pH 7.2). Tissue was incubated with the reaction mixture for 1.5 h at 37 degreesC in a humid chamber, using the kit from Roche Molecular Biochemicals (Laval, Quebec) at a volume of 20 mul per sample. A volume of 100 mul contained: double distilled water, 81 mul; TdT buffer, 6.5 mul; cobalt chloride, 3.26 mul; biotin-16-dUTP stock, at a concentration of 1 nmol/microl, 1.86 mul; dUTP, 5.5 mul; and TdT, at a concentration of 10 units/mul, 2 mul. Samples were then washed in PBS three times for 5 min each, and blocked with 3% skimmed milk in PBS containing 0.5% Tween-20 for 30 min. Samples were washed in PBS three times for 5 min each, and the fluorochrome, Streptavidin-FITC, was added at a concentration of 1:200, for 1 h at room temperature. Following 3 washes in PBS for 10 min each, the samples were taken through the immunocytchemistry procedure described above, using Alexa-Fluor 594 as the secondary antibody, and mounted on slides with Vectashield (Vector Laboratories Canada Inc., Burlington, Ontario). All cell counting was performed by manually counting each cell seen in the confocal images. All images of the retina were obtained from within approximately 5 mm of the optic nerve head. Sample sizes (n) are the combined numbers of cells from all three retina samples.
###end p 18
###begin title 19
Results
###end title 19
###begin p 20
###xml 72 80 72 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 762 770 762 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 960 969 960 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 858 864 <span type="species:ncbi:9986">rabbit</span>
###xml 893 898 <span type="species:ncbi:10090">mouse</span>
Immunocytochemical localization of GH and GHR in human retina sections (Figure 1) indicates that both are preferentially located in cells of the GCL, where they colocalized (yellow, in the merged image) in the nucleus as well as cytoplasm of many cells. Little or no GH was expressed in other cell layers. Analysis of the numbers of GH-positive or GHR-positive cells in the GCL from three different retina samples indicated that, overall, approximately 35% of cells in the GCL were GH-positive (n=56 cells), while a somewhat smaller number were GHR-positive. Because the GHR signal was weaker than the GH signal, the apparently lower number of GHR-positive cells may be due to the lower sensitivity of the technique. Cells of the inner and outer nuclear layers (Figure 1) were not immunoreactive for GH or GHR. When the primary antibodies were replaced with rabbit serum (for GH antiserum) or mouse IgG (for GHR antiserum), the immunoreactivity was abolished (Figure 2A).
###end p 20
###begin p 21
###xml 68 70 68 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 141 143 141 143 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 229 231 229 231 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 291 293 291 293 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</bold>
###xml 306 307 306 307 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 312 313 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human retina section immunocytochemically labeled for GH and GHR. A: DAPI labeling (blue) shows the position of all nuclei in the section. B: Growth hormone (GH) antiserum (green) labels cells in the ganglion cell layer (GCL). C: GH receptor (GHR) antibodies (red) label cells in the GCL. D: When panels B and C are merged, it is clear that GH and GHR are co-localized in the same cells (yellow). Abbreviations: inner nuclear layer (INL); outer nuclear layer (ONL). Scale bar equals 40 mum.
###end p 21
###begin p 22
###xml 90 92 86 88 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 350 352 346 348 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 206 212 <span type="species:ncbi:9986">rabbit</span>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
Human retina sections showing an immunocytochemical control and gamma-synuclein labeling. A: This image shows immunocytochemical labeling of a section in which growth hormone (GH) antiserum was replaced by rabbit serum and GH receptor (GHR) antibodies were replaced by mouse IgG. DAPI labeling (blue) shows the position of all nuclei in the section. B: This is an oblique section through the retina, labeled with an antibody against gamma-synuclein (green) to identify retinal ganglion cells (RGCs) in the ganglion cell layer (GCL). The majority of cells in the GCL show cytoplasmic labeling for synuclein. DAPI labeling (blue) shows the position of all nuclei in the section. Abbreviations: inner nuclear layer (INL); outer nuclear layer (ONL). Scale bar equals 40 mum.
###end p 22
###begin p 23
###xml 126 128 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 129 131 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 239 248 235 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 620 628 612 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
To confirm the identity of cells in the GCL, we labeled sections with an antibody against gamma-synuclein, a marker for RGCs [15,16]. The majority of cells in the GCL were preferentially labeled by this antibody, largely in the cytoplasm (Figure 2B). DAPI labeling was used as a cell marker of all cells. At least 95% (n=200 cells) of the cells in the GCL were labeled by this antibody. When the blocking peptide supplied by the manufacturer was added to the antibody before its use, immunoreactivity was abolished. Double labeling sections for gamma-synuclein (red) and GH (green) showed that GH was localized to RGCs (Figure 3; asterisks).
###end p 23
###begin p 24
###xml 66 68 62 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 172 174 164 166 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 242 244 234 236 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 272 273 264 265 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 278 279 270 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human retina section double-labeled for gamma-synuclein and GH. A: gamma-synuclein antibodies (red) label a retinal ganglion cell (RGC) in the ganglion cell layer (GCL). B: growth hormone (GH) antiserum (green) labels a nucleus in the GCL. C: The merged image of panels A and B shows that GH localizes to the same cell as gamma-synuclein, an RGC marker, (asterisks) indicating that this GH-containing cell is an RGC. DAPI labeling (blue) shows the position of all nuclei in the section. Abbreviations: ganglion cell layer (GCL); inner nuclear layer (INL). Scale bar equals 20 mum.
###end p 24
###begin p 25
###xml 73 81 73 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
Double labeling cells with GH and TUNEL for apoptotic DNA fragmentation (Figure 4) showed that positive immunoreactivity for GH always correlated with the absence of TUNEL labeling. Overall, based on three different retina samples, 46.4% of cells in the GCL were TUNEL-positive (n=56 cells). Of these, 100% were GH-negative (n=35 cells). Of the remaining TUNEL-negative cells, 32% were GH-negative (n=48 cells).
###end p 25
###begin p 26
###xml 78 80 78 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A:</bold>
###xml 239 241 239 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B:</bold>
###xml 311 312 311 312 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 314 316 314 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C:</bold>
###xml 380 381 380 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 383 385 383 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D:</bold>
###xml 448 449 448 449 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 624 625 624 625 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 629 630 629 630 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 634 635 634 635 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 639 640 639 640 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 648 649 648 649 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 686 687 686 687 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 691 692 691 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 696 697 696 697 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 701 702 701 702 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 706 707 706 707 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 711 712 711 712 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 716 717 716 717 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 725 726 725 726 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 786 787 786 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 791 792 791 792 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 800 801 800 801 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 12 17 <span type="species:ncbi:9606">human</span>
Sections of human retina immunocytochemically labeled for GH and dying cells. A: A section from a 74 year-old male labeled with DAPI (blue) for nuclei, growth hormone (GH) antiserum (red; asterisk); and TUNEL (green) for apoptotic nuclei. B: Another section from the same individual, labeled in the same way as A. C: A section from an 81 year-old male, labeled in the same way as A. D: A section from a 69 year-old male, labeled in the same way as A. With respect to cells in the ganglion cell layer (GCL), in the merged images, non-apoptotic and GH-positive nuclei appear red (asterisks) and correspond to nuclei numbered: A 5, B 2, C 1, D 2, and D 4. Apoptotic and GH-negative nuclei A 2, A 4, B 1, B 4, B 5, C 2, D 1, and D 3, appear blue-green. Non-apoptotic and GH-negative nuclei A 1, A 3, and B 3 appear blue. Abbreviations: inner nuclear layer (INL); outer nuclear layer (ONL). Scale bar equals 20 mum.
###end p 26
###begin p 27
###xml 3 11 3 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
In Figure 4, it can be seen that cells labeled A5, B2, C1, D2, and D4 (asterisks) are all GH-positive (red) and TUNEL-negative (red nuclei in the merged images). By contrast, cells A2, A4, B1, B4, B5, C2, D1, and D3 are TUNEL-positive (green) but GH-negative (blue-green nuclei in the merged images). Approximately 18% of cells are both TUNEL-negative and GH-negative (A1, A3, and B3; blue in the merged images).
###end p 27
###begin title 28
Discussion
###end title 28
###begin p 29
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 805 807 805 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 1118 1119 1118 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 1120 1121 1120 1121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 1122 1123 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 264 269 <span type="species:ncbi:9606">human</span>
###xml 895 900 <span type="species:ncbi:9606">human</span>
###xml 1000 1005 <span type="species:ncbi:9031">chick</span>
There are limited experimental options available for use in attempts to establish a functional role for endogenous GH in adult human RGCs. In this study, we chose to correlate the presence of immunoreactive GH with a marker of cell death in the GCL from sectioned human retinas. We found that cells of the GCL that contained TUNEL-positive nuclei never expressed GH immunoreactivity in their nucleus or cytoplasm. Of the remaining cells that contained TUNEL-negative nuclei, two-thirds had GH in the cytoplasm as well as nuclei. Labeling of sections with the RGC marker synuclein [15,16], indicated that at least 95% of the cells in the GCL were RGCs, leading us to conclude that the majority of the cells that we have examined in the GCL are RGCs and not cells displaced from other layers of the retina [17]. This result therefore provides us with circumstantial evidence that endogenous GH in human RGCs may have a role in cell survival, and is consistent with our previous experimental studies on chick RGCs showing that GH has anti-apoptotic properties both in vivo and in vitro in these cells during development [6,8,9].
###end p 29
###begin p 30
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
One third of the TUNEL-negative RGCs apparently did not express GH. We conclude that GH is sufficient, but not necessary, for RGC survival. Presumably, such cells may receive survival signals from other molecules, since GH is by no means the only neuroprotective molecule present in the retina [18].
###end p 30
###begin p 31
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 760 761 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 622 627 <span type="species:ncbi:9031">chick</span>
We found that 46% of the cells in the GCL of our samples were TUNEL-positive. This number of apoptotic cells may be attributed not only to natural cell death in this layer, but also possibly to postmortem cell death, since fixation of the specimens was performed between 2 and 13 h postmortem. However, evidence from examination of retinas after optic nerve transection [19] indicates that RGCs survive for several days after this insult. It is likely that GH is able to rescue RGCs irrespective of the cause of cell death in the GCL, whether owing to disease or whether it is post-mortem, since our in vitro results with chick RGCs show that GH is also able to protect these cells from apoptosis after axotomy [19] that is performed to culture the cells [6,8,9].
###end p 31
###begin p 32
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
That GH and GHR are mostly colocalized to the nuclei is not unexpected; it has long been known that both GHR and GH are associated with the nucleus [20]. Technically, we performed the more complex TUNEL procedure before the immunocytochemistry. In contrast to GH, immunoreactivity for GHR did not survive the TUNEL procedure, presumably because of the weaker immunoreactivity of GHR in comparison with GH. It is unlikely that the TUNEL procedure inhibits subsequent GH immunoreactivity, because the GH immunoreactivity clearly survives the proteinase-K treatment (compare cell A4 with A5; and B1 with B2), which is the only step in the TUNEL procedure likely to interfere with GH immunoreactivity.
###end p 32
###begin p 33
###xml 281 282 281 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 72 80 <span type="species:ncbi:9606">patients</span>
###xml 319 327 <span type="species:ncbi:9606">patients</span>
On the basis of these results, the question arises as to whether or not patients with low systemic GH levels experience retinal cell death or other retinopathies. Bearing in mind that systemic levels of pituitary GH may not be relevant to the ocular levels of locally produced GH [7], the literature suggests that such patients may indeed exhibit ocular dysfunction [21]. Dysfunctions related to GH deficiency include: reduced retinal vascularization, optic disc and optic nerve hypoplasia, Jacobsen syndrome, Cockayne syndrome, and a rare form of retinitis pigmentosa (RHYNS syndrome) characterized by hypopituitarism, GH deficiency, and skeletal dysplasia [21].
###end p 33
###begin title 34
Conclusion
###end title 34
###begin p 35
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 24 29 <span type="species:ncbi:9606">human</span>
We conclude that in the human retina, the presence of GH in the RGCs correlates with the survival of these cells. This conclusion is consistent not only with our previous experimental results [6,8,9], but also with a growing literature indicating the general anti-apoptotic and neuroprotective effects of GH [22] in diverse cell types including: myoblasts [23], myocytes [24], neonatal brain neurons [25], and cells of the immune system [26].
###end p 35
###begin title 36
Acknowledgments
###end title 36
###begin p 37
We thank Dr. Yves Sauve for valuable discussion and Rory Thompson for preliminary data. This work was supported by grant 349900-07 from the Natural Sciences and Engineering Research Council of Canada.
###end p 37
###begin title 38
References
###end title 38
###begin article-title 39
###xml 30 35 <span type="species:ncbi:9031">chick</span>
Retinal growth hormone in the chick embryo.
###end article-title 39
###begin article-title 40
Growth hormone in the visual system: comparative endocrinology.
###end article-title 40
###begin article-title 41
###xml 33 38 <span type="species:ncbi:9606">human</span>
Growth hormone is present in the human retina and vitreous fluid.
###end article-title 41
###begin article-title 42
Opticin binds retinal growth hormone in the embryonic vitreous.
###end article-title 42
###begin article-title 43
Growth hormone as an early embryonic growth and differentiation factor.
###end article-title 43
###begin article-title 44
Retinal growth hormone is an anti- apoptotic factor in embryonic retinal ganglion cell differentiation.
###end article-title 44
###begin article-title 45
Peptide hormones as developmental growth and differentiation factors.
###end article-title 45
###begin article-title 46
Retinal ganglion cell survival in development: mechanisms of retinal growth hormone action.
###end article-title 46
###begin article-title 47
Growth hormone-mediated survival of embryonic retinal ganglion cells: signaling mechanisms.
###end article-title 47
###begin article-title 48
###xml 67 72 <span type="species:ncbi:9031">chick</span>
Growth hormone-induced neuroprotection in the neural retina during chick embryogenesis.
###end article-title 48
###begin article-title 49
The neurobiology of cell death in glaucoma.
###end article-title 49
###begin article-title 50
Gene therapy for optic nerve disease.
###end article-title 50
###begin article-title 51
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human pituitary adenomas in cell cultures by light and electron microscopic morphology and immunolabeling.
###end article-title 51
###begin article-title 52
###xml 73 81 <span type="species:ncbi:9606">children</span>
Expression of growth hormone receptor by peripheral blood lymphocytes in children: evaluation in clinical conditions of impaired growth.
###end article-title 52
###begin article-title 53
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Retinal ganglion cells downregulate gene expression and lose their axons within the optic nerve head in a mouse glaucoma model.
###end article-title 53
###begin article-title 54
gamma-synuclein as a marker of retinal ganglion cells.
###end article-title 54
###begin article-title 55
The pigeon retina: quantitative aspects of the optic nerve and ganglion cell layer.
###end article-title 55
###begin article-title 56
Retinal neuroprotection by growth factors: a mechanistic perspective.
###end article-title 56
###begin article-title 57
###xml 82 86 <span type="species:ncbi:10116">rats</span>
Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats.
###end article-title 57
###begin article-title 58
Nuclear translocation and anchorage of the growth hormone receptor.
###end article-title 58
###begin article-title 59
Growth hormone and developmental ocular function: clinical and basic studies.
###end article-title 59
###begin article-title 60
Aspects of growth hormone and insulin- like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain.
###end article-title 60
###begin article-title 61
Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts.
###end article-title 61
###begin article-title 62
GH prevents apoptosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism.
###end article-title 62
###begin article-title 63
###xml 97 100 <span type="species:ncbi:10116">rat</span>
Protective effect of growth hormone on neuronal apoptosis after hypoxia-ischemia in the neonatal rat brain.
###end article-title 63
###begin article-title 64
Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways.
###end article-title 64

